GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
FDA Widens Access to Marstacimab-hncq for Hemophilia A and B - Hematology Advisor
Management of Colonic Intramural Hematoma Complicated by Intestinal Obstruction in a Patient With Hemophilia: A Case Report and Literature Review - Cureus
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors - NEJM
Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program - BioSpace
B cell therapy maker Be Bio stops hemophilia trial - Endpoints News
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi - Fierce Pharma
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Marstacimab-hncq (Hympavzi) Gains FDA Approval for Expanded Hemophilia A and B Indication in Patients Aged 6 Years and Older - Consultant360
FDA Expands Marstacimab Indication in Hemophilia A and B - Conexiant
Activated factor VIII-mimetic prophylaxis associated with reduced bleeding in hemophilia A - 2 Minute Medicine
Prenatal cell and gene therapy for hemophilia A shows safety signs - Hemophilia News Today
Hemophilia Treatment Market Industry Report & Forecast 2035 - Business Research Insights
Global Hemophilia Survey Amplifies Patient and Caregiver Voices - Sanofi
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Refractory Hemorrhage Following Total Knee Replacement Unmasking Acquired Hemophilia A - Cureus
FDA expands Hympavzi approval to more hemophilia patients - Hemophilia News Today
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
FDA grants fast track status to 1-time stem cell therapy for hemophilia A - Hemophilia News Today
Mim8 Prophylaxis Shows Durable Bleed Control at 52 Weeks in Hemophilia A - Docwire News
Lower-dose gene therapy effective in severe hemophilia A: Study - Hemophilia News Today
Acquired Hemophilia A During Prasugrel Therapy After Recurrent Acute Coronary Syndrome - JACC Journals
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM - PR Newswire
Denecimig excels at reducing bleeds in hemophilia A patients: Study - Hemophilia News Today
3 years on Hemlibra keeps joints healthy in kids with hemophilia A - Hemophilia News Today
FDA Expands Pfizer’s Hympavzi Approval to Pediatric Hemophilia Patients and Those with Inhibitors - BioPharm International
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients - PR Newswire
Delayed diagnosis of hemophilia A presenting as chronic joint swelling: a case report - Frontiers
Geneventiv notes FDA ‘positive’ feedback on hemophilia A therapy - Hemophilia News Today
Hemlibra outperforms ITI in controlling bleeding in hemophilia A children - Hemophilia News Today
It’s Time to Look Beyond the Bleed - Sanofi
Improving Health-Related Quality of Life for Children With Hemophilia - Hematology Advisor
Real-world study backs safety of Hemlibra for acquired hemophilia A - Hemophilia News Today
New deal aims to bring BBM’s hemophilia A gene therapy to China - Hemophilia News Today
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
Hemophilia Studies Today: Points of Interest - Docwire News
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Hemophilia A or B without inhibitors: marstacimab prophylaxis now an FDA-approved option from age 12 - Vera Health
Real-World Use of Efanesoctocog Alfa Shows Benefit in Severe Hemophilia A - Hematology Advisor
New CAAR-T therapy may eliminate hemophilia A treatment blockers: Study - Hemophilia News Today
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Investigational Stem Cell Therapy for Hemophilia A - PR Newswire
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Abstract - 2026 - Haemophilia - Wiley Online Library
Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A - MedPage Today
Michigan man gets new Roctavian gene therapy for hemophilia A - Detroit Free Press
Doctors warn eye bleeding can be first sign of hemophilia A - Hemophilia News Today
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Efanesoctocog Alfa Improves Bleeding Regardless of Age in Hemophilia A, With Lynn Malec, MD, MSc - HCPLive
Clinical Scenarios in Hospitalized Patients With Hemophilia - Cureus
Efanesoctocog Alfa Improves Outcomes for Patients With Hemophilia A - Docwire News
Silent Avascular Necrosis of the Femoral Head in Severe Hemophilia A: A Case Report - Cureus
Evolving treatment paradigms in hemophilia: A written recap - Managed Healthcare Executive
Novo Nordisk Submits Denecimig (Mim8) BLA for Hemophilia A - HCPLive
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
Ongoing Trial Investigates Switching from Emicizumab to Fitusiran in Hemophilia A, With Guy Young, MD - HCPLive
Balancing the benefits and risks of rebalancing coagulation in haemophilia - The Lancet
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Byron family shares son’s journey with Severe Hemophilia A - MyStateline
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts - Wiley Online Library
Hand swelling is first sign of aquired hemophilia A for new mom: Report - Hemophilia News Today
Infection is top killer in acquired hemophilia A, study finds - Hemophilia News Today
Building safeguards for gene therapy in haemophilia - The Lancet
FRONTIER Trials Support BLA for Investigational Hemophilia A Drug - Docwire News
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - BioSpace
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline - Wiley Online Library
FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors - Contemporary Pediatrics
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
BioMarin pulls hemophilia gene therapy Roctavian, taking $240M hit after divestiture efforts flounder - Fierce Pharma
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - Yahoo Finance
Biomarin plans to sell rights to hemophilia A therapy Roctavian - Hemophilia News Today
Standard or low-dose rituximab effective for acquired hemophilia A - Hemophilia News Today
Acquired Hemophilia A With Post‐Phlebotomy Compartment Syndrome - Lam - 2025 - Clinical Case Reports - Wiley Online Library
Phase 3 Study Evaluates Marstacimab for Hemophilia A, B, Without Inhibitors - Docwire News
JW's Hemlibra effective in improving joint health, physical activity in hemophilia A patients - koreabiomed.com
Denecimig significantly reduced annualized bleeding rate in people with hemophilia A - The Pharma Letter
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors - Contract Pharma
Diffuse alveolar hemorrhage in a child with mild hemophilia A who underwent bone marrow transplantation for thalassemia: a case report - Frontiers
Newly ID’d F8 mutation could lead to better hemophilia A treatments - Hemophilia News Today
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
‘Dismissed’: A film that finally gives women with hemophilia a voice - Hemophilia News Today
Hemophilia gene therapies are struggling on the market, even as innovation soars - pharmavoice.com
BioMarin resigned to ending journey with hemophilia A gene therapy Roctavian, seeks divestiture amid sales struggle - Fierce Pharma
'Gene therapy with 13-year durability pushes hemophilia closer to a functional cure' - koreabiomed.com
Case Report of acupotomy release combined with manual release under anesthesia for adhesions after unilateral total knee arthroplasty in a patient with hemophilia A - Frontiers
Pfizer confirms patient death in Hympavzi hemophilia extension study - Fierce Pharma
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program - BioSpace
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Hemophilia Market Size, Share, Growth | CAGR of 6.9% - Market.us
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
AI-Driven Applications Changing the Management of Hemophilia - Hematology Advisor
More Hemophilia Treatment Choices Despite Gene Therapy Setbacks - Managed Healthcare Executive
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemophiliaa a,   hemophliia a,   hemophilia a,   hemohpilia a,   gemophilia a,   hemohilia a,   hemophi;ia a,   hemophiila a,   hemopgilia a,   hemophiilia a,   hmeophilia a,   jemophilia a,   emophilia a,   hemopphilia a,   hemopihlia a,   hemophilis a,   hemophili aa,   hemophiliaa ,   hemophhilia a,   hemo[hilia a,   hemophila a,   hemophilai a,   hempohilia a,   hemophilia s,   heemophilia a,   hempphilia a,   hemophiliia a,   hemophlia a,   ehmophilia a,   hrmophilia a,   hemophillia a,   hemopholia a,   hemophikia a,   heophilia a,   he,ophilia a,   hemphilia a,   hwmophilia a,   hemopilia a,   hemophilua a,   hmophilia a,   hemopjilia a,   hemophiloa a,   hemophilia aa,   hemophiliaa,   hemoophilia a,   hemiphilia a,   hhemophilia a,   heomphilia a,   hemmophilia a,   hemophiia a,   hemophili a,   hemophulia a,   hemoohilia a,   henophilia a,   hemophilia
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z